A large-scale prospective study of bezafibrate in 6,000 Japanese dyslipidemic patients with type 2 diabetes (J-BENEFIT study)

Tamio Teramoto, Kohji Shirai, Hiroyuki Daida, Nobuhiro Yamada

Research output: Contribution to journalArticle

Original languageEnglish
JournalDIABETES
Volume56
StatePublished - Jun 2007

Cite this